Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Perrigo's Infant Formula Already A Key Sales Driver, And Nutrition Sector Takes Larger Role Ahead

Mar 01 2020

• By Malcolm Spicer

4th quarter computer key on key board

Related Content

Perrigo Out From Under VMS Weight As IVC Lifts Private Label Profile

Jun 21 2016

Amazon OTCs Likely A Worry For Retailers, A Remedy For Perrigo

Jan 09 2018

US OTC Switch Drought Ends: FDA Approves GSK Arthritis Gel, Alcon Allergy Eye Drops

Feb 17 2020

Perrigo Reports Broad Growth, But Investors Sour On Turnaround's Price Tag

Feb 28 2020

Perrigo Faces $370m Tax Payment From Second IRS Audit Linked To Elan Deal

Nov 07 2019

Perrigo's Turnaround Tools: 'National Brand,' Novel NRTs, CBD And Natural Products, Sponsoring OTC Switches

May 13 2019

Infant Formula Woes Turn Perrigo's Q2 Sour Despite Solid Americas’ OTC Sales

Aug 09 2019

Related Companies

Perrigo Company PLC

GSK plc

Additional Topics

International United States South America Sales & Earnings OTC Drugs Dietary Supplements Advertising, Marketing & Sales Business Strategies Commercial Companies Growth Manufacturing Prescription To OTC Switch Consumer

More from International

More from Geography

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window